News

Filter

Current filters:

apixaban

Decline in cardiovascular drugs noted at ESC congress

17-09-2012

This year's European Society of Cardiology (ESC) Congress in Munich, Germany, was a stark example of…

apixabanBristol-Myers SquibbCardio-vascularEliquisMarkets & MarketingPfizerPharmaceuticalResearch

Bristol-Myers and Pfizer’s Eliquis first oral anticoagulant to significantly reduce all-cause death

30-08-2011

In much anticipated research news, US drug majors Bristol-Myers Squibb (NYSE: BMY) and Pfizer (NYSE:…

apixabanBristol-Myers SquibbCardio-vascularEliquisPfizerPharmaceuticalResearch

Early closing of apixaban trial on good results in AF sees Pfizer and Bristol-Myers Squibb shares rise

14-06-2010

US drug majors Pfizer and Bristol-Myers Squibb saw their share prices rise on Friday after announcing…

apixabanBristol-Myers SquibbCardio-vascularPfizerPharmaceuticalResearch

Back to top